Well, I certainly hate to totally disagree with your first post here, but maybe a can poke a few holes in your claim. First read this (one of many articles on the subject):
IF NASDAQ rejected CYTR's request for another extension, which I seriously doubt under the circumstances, there's an appeals process that will allow time for CYTR to take other action to correct the deficiency(s).
CYTR's market cap, recent partnership, share movement/volume and market manipulation all support their continued listing. The BOD situation that Tek mentioned, if not in compliance, can and will be remedied soon enough and is a non-issue, IMO.
If folks are selling at a loss because of possible delisting I'll be buying some of those shares next week and wait for the "Official" word on the granting of an extension, at best, or an appeal of a rejection, at worst.
I've posted my opinions on this before yet the Chicken Little's continue to declare that the sky is falling when in fact they should be enjoying the apple that just landed on their head.;p
News 
Market Data 
Discover 
